摘要
目的探究不同抗血小板药物对冠心病患者的临床疗效。方法将2015年1月~2017年12月收治的136例冠心病患者,随机分组,对照组(氯吡格雷)、治疗组(普拉格雷),每组68例,对两组治疗效果进行分析和对比。结果治疗组治疗效果好于对照组(P <0.05),治疗组药物不良反应发生情况低于对照组(P <0.05)。结论普拉格雷对冠心病患者具有理想的临床治疗效果,并且药物安全性较高、药物起效加快、药效持久。
Objective To explore the clinical therapeutic effect of oral antiplatelet drugs on patients with coronary heart disease.Methods According to the clinical data of 136 patients with coronary heart disease treated in our hospital from January 2015 to December 2017,they were randomly divided into the control group(clopidogrel group)and the treatment group(prasugrel group),each group had 68 patients,and the therapeutic effects of two groups were compared.Results The therapeutic effect of the treatment group was better than that of the control group(P<0.05),and the adverse drug reactions of the treatment group were better than that of the control group(P<0.05).Conclusion Oral antiplatelet drugs have ideal clinical therapeutic effect on patients with coronary heart disease,and drug safety is high,drug onset is accelerated,lasting efficacy,can be promoted in the medical industry.
作者
周斐昊
ZHOU Fei-hao(Yiqi Hospital,Changchun 130000,China)
出处
《中国处方药》
2018年第12期89-90,共2页
Journal of China Prescription Drug
关键词
冠心病
普拉格雷
氯吡格雷
治疗效果究
Coronary heart disease
Prasugral
Clopidogrel
Therapeutic effect